Martin Brenner

Chief Executive Officer at IBIO, INC.

Net worth: 58 239 $ as of 31/05/2026

56 year

Health Technology

Consumer Services

Profile

Martin B. Brenner currently works at iBio, Inc., as Director, Chief Executive & Scientific Officer from 2024.
Dr. Brenner also formerly worked at AstraZeneca PLC, as Senior Director & Head-BioScience from 2012 to 2013, Merck Research Laboratories Massachusetts LLC, as Executive Director-Diabetes & NASH from 2013 to 2016, Recursion Pharmaceuticals, Inc., as Chief Scientific Officer from 2017 to 2018, Pelican, Inc., as Chief Scientific Officer & Senior Vice President from 2019 to 2020, Stoke Therapeutics, Inc., as VP & Head-Research & Early Development from 2016 to 2017, and Pfizer Inc., as Head-Insulin Resistance Group.
Dr. Brenner received his doctorate degree from Ludwig-Maximilians-Universität München and doctorate degree from The University of Veterinary Medicine Hanover.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IBIO, INC. 0.09%	19/03/2026	30,652 ( 0.09% )	58 239 $	31/05/2026

Martin Brenner active positions

Companies	Position	Start
IBIO, INC.	Chief Executive Officer	20/01/2023

All active positions of Martin Brenner

Former positions of Martin Brenner

Companies	Position	End
PFENEX INC.	Chief Tech/Sci/R&D Officer	01/10/2020
RECURSION PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/01/2018
STOKE THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2017
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Director/Board Member	01/01/2016
ASTRAZENECA PLC	Corporate Officer/Principal	01/01/2013

See the detail of Martin Brenner's experience

Training of Martin Brenner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Brenner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Recursion Pharmaceuticals, Inc. Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
iBio, Inc. iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins	Health Technology
Pelican Inc Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines	Health Technology
The University of Veterinary Medicine Hanover The University of Veterinary Medicine Hanover Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases	Health Technology